Clinical Trials Decriminalization Patients State Laws 
Canna Law Blog
NOVEMBER 10, 2020
We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in certain cases, reliance on Right to Try access. Unlike with many precursor state laws, no institutional review board review is required.
NORML
JANUARY 4, 2019
Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. MA resident? Click here to email your lawmakers in support of consumer employment protections.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
JANUARY 18, 2019
House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. Virgin Islands. IN resident?
The Blunt Truth
AUGUST 13, 2019
Other CBD products, however, are still subject to various state law regulations as well as the U.S. The FDA is also meeting with other federal agencies and state counterparts, trade organizations, and patient groups in a quest for data. To further complicate matters, there has been a flurry of activity at the state level.
Canna Law Blog
MARCH 4, 2020
Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).
Canna Law Blog
MARCH 4, 2020
Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).
The Cannigma
MARCH 12, 2021
But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. So, you have this attempt to legitimize healthcare and to adopt standards, to do things in a more scientific way, and in a more credible way, for patients and for industry. It’s a non-trivial issue.
Expert insights. Personalized for you.
78 
Let's personalize your content